We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current LAB market cap is 295.51M. The company's latest EPS is USD 0.2 and P/E is -6.08.
| Quarter End | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 20.22M | 21.76M | 19.55M | 23.8M | 21.15M |
| Operating Income | -24.22M | -23.7M | -23.47M | -21.92M | -9.42M |
| Net Income | -26.03M | -33.46M | -34.69M | 19.28M | 127.07M |
| Year End December 31 2025 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 130.58M | 97.95M | 106.34M | 91.01M | 85.33M |
| Operating Income | -67.46M | -99.09M | -63.04M | -87.01M | -93.31M |
| Net Income | -59.24M | -190.1M | -74.66M | -138.89M | -74.9M |
| Quarter End | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 579.6M | 556.97M | 539.64M | 567.75M | 639.11M |
| Total Liabilities | 125M | 132.43M | 139.98M | 143.46M | 77.99M |
| Total Equity | 454.6M | 424.54M | 399.66M | 424.29M | 561.12M |
| Year End December 31 2025 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 275.21M | 390.31M | 323.07M | 612.35M | 567.75M |
| Total Liabilities | 180.62M | 160.52M | 159.87M | 140.62M | 143.46M |
| Total Equity | 94.6M | 229.79M | 163.2M | 471.72M | 424.29M |
| Quarter End | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -30.28M | -20.67M | -22.2M | -1.19M | -46.6M |
| Investing | 14.63M | 27.51M | -6.68M | -8.04M | 191.09M |
| Financing | -46k | 108k | -112k | 620k | -40k |
| Year End December 31 2025 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -44.06M | -89.37M | -43.29M | -143.45M | -74.34M |
| Investing | -11.95M | -88.13M | 20.24M | 363.17M | 27.41M |
| Financing | 15.96M | 230.76M | -6.81M | -102.62M | 570k |
| Market Cap | 295.509M |
| Price to Earnings Ratio | -6.08 |
| Price to Sales Ratio | 3.58 |
| Price to Cash Ratio | 0.68 |
| Price to Book Ratio | 0.55 |
| Dividend Yield (LTM) | N/A |
| Shares Outstanding | 390.37M |
| Average Volume (1 week) | 3.61M |
| Average Volume (1 Month) | 4.39M |
| 52 Week Change | - |
| 52 Week High | 1.72 |
| 52 Week Low | 0.7386 |
| Spread (Intraday) | 0.1 (11.9%) |
| Company Name | Standard BioTools Inc |
| Address |
50 Milk Street Boston, Massachusetts 02109 |
| Website | https://www.standardbio.com |
| Industry | Biotechnology & Life Sciences |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Register with Email
Already have an account? Sign in
Don't have an account? Sign up
By registering, I confirm I have read, understand, and agree to ADVFN's Terms and Conditions and that I am a private investor.
Hot Features
Premium
